The Zonulin Serum ELISA is intended for the quantitative determination of zonulin family peptides in human serum samples. Formerly product 30-ZONSHU-E01.
For Research Use Only. Not for Use in Diagnostic Procedures.
This assay is based on the method of competitive ELISA. As a first preparation step, a biotinylated zonulin family peptides (ZFP) tracer is added to the samples, standards, and controls. Afterwards, aliquots of the treated samples, standards, and controls are transferred and incubated in microtiter plate wells coated with polyclonal anti-ZFP antibodies. During the incubation, the free target antigen in the samples competes with the biotinylated ZFP tracer for the binding of the polyclonal anti-ZFP antibodies immobilized on the microtiter plate wells. The unbound components are removed by a washing step. During a second incubation step, peroxidase-labeled streptavidin, which binds to the biotinylated ZFP tracer, is added into each microtiter well. After a washing step to remove the unbound components, the peroxidase substrate tetramethylbenzidine (TMB) is added. Finally, the enzymatic reaction is terminated by an acidic stop solution. The color changes from blue to yellow and the absorbance is measured in the photometer at 450 nm. The intensity of the yellow color is inversely proportional to the ZFP concentration in the sample; this means, high ZFP concentration in the sample reduces the concentration of the biotinylated ZFP tracer bound to the immobilized anti-ZFP antibodies and lowers the photometric signal. A dose response curve of absorbance unit (optical density, OD at 450 nm) versus concentration is generated using the values obtained from the standard. Zonulin family peptide levels in the samples are determined directly from this curve.
Species
Human
Regulatory Status
Research Use Only. Not for Use in Diagnostic Procedures.
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
In a head-to-head comparison of FDA-cleared assays and a novel ALPCO method, investigators observed wide variability in specificity and false-positive rates across platforms, raising important questions about standardization and clinical interpretation.
July 22, 2025 – Salem, NH – NuvinkaDx, a leading innovator in diagnostic solutions, today announced two significant product and regulatory milestones from its operating companies, GeneProof and ALPCO.
Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.
Complement System Solutions for Drug Development and Clinical Research Datasheet
The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.
Melatonin Products for Sleep Disorder-Related Research Datasheet
The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.
